San Diego-based mostly Viking Therapeutics marked by itself as a serious competitor while in the weight loss drug marketplace in February immediately after revealing promising info from the mid-phase demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when offered for a weekly injection As well as